今日观察！A Wave of "Kete Valuation" Sweeps Through the Market: 50 Stocks Poised for Strong Growth

A Wave of "Kete Valuation" Sweeps Through the Market: 50 Stocks Poised for Strong Growth

Shanghai, China - June 17, 2024 - A recent surge in investor sentiment towards growth stocks, particularly in the healthcare and technology sectors, has been dubbed the "Kete Valuation" phenomenon, named after the Chinese pharmaceutical company C-Bridge (6160.HK). This trend is reminiscent of the "CATL Valuation" rally that occurred in 2021, driven by the strong performance of Contemporary Amperex Technology Co., Ltd. (300015.SZ).

The "Kete Valuation" is characterized by a sharp increase in the share prices of companies with promising growth prospects, often defying broader market trends. This is evident in the recent performance of 50 stocks identified by analysts as having significant growth potential. These stocks, spanning various industries including healthcare, technology, and consumer goods, have exhibited remarkable resilience amidst recent market volatility.

Factors Driving the "Kete Valuation"

Several factors are contributing to the "Kete Valuation" trend. Firstly, investors are increasingly seeking out companies that can deliver sustainable growth, particularly in the face of global economic uncertainties. Secondly, the easing of monetary policy in major economies is providing a supportive backdrop for riskier assets like growth stocks. Additionally, advancements in technology and innovation are creating new opportunities for companies in various sectors, fueling investor optimism.

Key Beneficiaries of the "Kete Valuation"

Among the 50 stocks identified as potential beneficiaries of the "Kete Valuation," C-Bridge (6160.HK) stands out as a frontrunner. The company's innovative cancer therapies and strong pipeline of new drugs have attracted significant investor interest. Other notable stocks include:

• Ascletis Pharma (1672.HK): A clinical-stage biopharmaceutical company developing novel therapies for cancer and viral diseases.

• Aier Eye Hospital Group (300015.SZ): A leading provider of comprehensive eye care services in China.

• Xiaomi Corporation (1810.HK): A global technology company known for its smartphones, smart home devices, and internet services.

Investment Implications

The "Kete Valuation" presents an opportunity for investors to capitalize on the growth potential of select companies. However, careful due diligence is crucial, as not all growth stocks are created equal. Investors should thoroughly evaluate a company's financial health, competitive landscape, and long-term growth prospects before making investment decisions.

The "Kete Valuation" highlights the evolving dynamics of the Chinese stock market, where investors are increasingly discerning and seeking out companies with genuine growth potential. This trend is likely to continue as China's economy transitions towards a more innovation-driven and knowledge-based model.

新浪观影团送福利！《满江红》卢米埃影城免费观影等你来

北京 - 2023年1月29日（农历正月初八），由新浪观影团主办的《满江红》卢米埃影城免费观影活动在北京隆重举行。活动现场气氛热烈，20位幸运获奖观众观看了这部备受期待的古装悬疑喜剧电影，并对影片进行了精彩点评。

本次活动由新浪微博知名电影大V@新浪观影团发起，旨在为影迷朋友们送上新春福利，让大家能够在大年初八享受一场欢乐的观影盛宴。活动消息一经发布，便吸引了众多网友的关注和参与。经过激烈角逐，最终20位幸运观众脱颖而出，获得了免费观影名额。

1月29日下午，20位获奖观众早早来到位于北京朝阳区长楹天街购物中心的卢米埃影城长楹天街店。在工作人员的引导下，他们顺利完成了签到领票手续，并入场观看了电影《满江红》。

电影《满江红》由张艺谋执导，沈腾、易烊千玺、雷佳音、张译、岳云鹏、王佳怡等主演。影片讲述了南宋绍兴年间，秦桧率兵与金国会谈前夜，金国使者死在宰相驻地，所携密信也消失无踪。小兵张大与亲兵营副统领孙均机缘巧合被裹挟进这巨大阴谋之中，宰相秦桧命两人限一个时辰之内找到凶手。伴随危机四伏的深入调查，宰相府总管何立、副总管武义淳、舞姬瑶琴等人卷入局中，案件的背后似乎隐藏着一场更大的阴谋。

电影上映后，观众们纷纷表示被精彩的剧情和出色的表演所吸引。有观众表示，电影的悬疑氛围营造得非常到位，全程都跟着主角们一起烧脑推理；也有观众表示，几位主演的演技都非常炸裂，尤其是沈腾和易烊千玺的对手戏，笑料十足，让人印象深刻。

观影结束后，获奖观众们还积极参与了映后点评活动，分享了他们对电影的观后感。不少观众表示，这部电影不仅好看，而且发人深省，值得一看。

新浪观影团表示，一直以来都致力于为影迷朋友们提供优质的观影体验。未来，将继续推出更多精彩的观影活动，回馈广大影迷朋友的支持。

## 活动详情

• 活动时间：2023年1月29日（农历正月初八）
• 活动地点：北京卢米埃影城长楹天街店
• 活动奖品：电影《满江红》电影票
• 获奖人数：20人

## 如何参与

1. 关注@新浪观影团微博
2. 转发活动微博并带话题#新浪观影团# #满江红#
3. 点击下方链接参与活动报名：https://weibo.com/

## 活动规则

1. 每人限参与一次，转发微博内容不得修改。
2. 中奖名单将于1月28日公布，获奖者将收到@新浪观影团私信通知。
3. 中奖者需凭有效身份证件于1月29日下午10点前到北京卢米埃影城长楹天街店领取电影票。
4. 本活动最终解释权归新浪观影团所有。